Reference
- Novak SP, Håkansson A, Martinez-Raga J, Reimer J, Krotki K, Varughese S. Nonmedical use of prescription drugs in the European Union. BMC Psychiatry 2016;16:274
References
- Hamilton CW, Gertel A, Jacobs A, Marchington J, Weaver S, Woolley K. Mythbusting Medical Writing: Goodbye, Ghosts! Hello, Help! Account Res 2016;23:178-94
- AMWA–EMWA–ISMPP Joint Position Statement on the Role of Professional Medical Writers. Medical Writing 2017;26:7-8
- Winchester C. Advancing the medical writing profession: the Joint Position Statement on the role of the professional medical writer. Medical Writing 2017;26:6
References
- Marchington JM, Burd GP. Author attitudes to professional medical writing support. Curr Med Res Opin 2014;30:2103-2108
- Winchester C. AMWA-EMWA-ISMPP Joint Position Statements on the role of professional medical writers. Medical Writing 2017;26:7-8
Reference
- Carey LC, Stretton S, Kenreigh CA, Wagner LT, Woolley KL. High nonpublication rate from publication professionals hinders evidence-based publication practices. PeerJ 2016;4:e2011
Reference
- Fox CS, Barry K, Colbert J. Importance of social media alongside traditional medical publications. Circulation 2016;133:1978-83
References
- Sharma NS. Patient centric approach for clinical trials: Current trend and new opportunities. Perspect Clin Res 2015;6:134-8
- Javaid MK, Forestier-Zhang L, Watts L, et al. The RUDY study platform – a novel approach to patient driven research in rare musculoskeletal diseases. Orphanet J Rare Dis 2016;11:150
- Woodward L, Johnson S, Walle JV, et al. An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry. Orphanet J Rare Dis 2016;11:154
Reference
- Great Ormond Street Hospital. Scale of Rare Diseases. Available at: http://www.gosh.org/what-we-do/research/zayed-centre-research-rare-disease-children/rare-diseases/scale-rare-diseases. [Last accessed 2 October 2017]